Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer

British Journal of Cancer

Volumn 85, Issue 4, 2001, Pages 576-583

  West, A F ^a   O'Donnell, M ^b   Charlton, R G ^b   Neal, D E ^a   Leung, H Y ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Benign prostatic hyperplasia (BPH); Fibroblast growth factor 8 (FGF 8); Immunohistochemistry; Prostate cancer; Survival; Vascular endothelial growth factor (VEGF)

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STROMA CELL; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035902804     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1971     Document Type: Article

References (41)

1. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
2. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian cancer
3. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumour cells, and outcome in prostate cancer patients subjected to watchful waiting
4. How tumours become angiogenic
5. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
6. Peptide growth factors in the prostate as mediators of stromal epithelial interaction
7. Tumour vascular permeability factor stimulates endothelial cell growth and angiogenesis
8. The fms like tyrosine kinase, a receptor for vascular endothelial growth factor
9. FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease
10. aFGF immunoreactivity in prostate cancer and its co-localisation with bFGF and FGF8
11. Molecular and biological properties of the vascular endothelial growth factor family of proteins
12. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells
13. Expression of vascular endothelial growth factor receptors in human prostate cancer
14. What is the evidence that turnouts are angiogenesis dependent?
15. Structure and sequence of human FGF8
16. Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma
17. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relation ship to neuroendocrine cells
18. Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system
19. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia
20. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue
21. Prostatic carcinoma
22. Angiogenic cytokines in mesothelioma: A study of VEGF FGF-1 and -2, and TGFbeta expression
23. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis
24. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
25. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients
26. Potential synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
27. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
28. Hormonal therapy of prostate cancer
29. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
30. Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
31. Topography of neovascularity in human prostate carcinoma
32. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells
33. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer
34. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
35. Cloning and characterization of an androgen-induced growth factor essential for the androgen-independent growth of mouse mammary carcinoma cells
36. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralising monoclonal antibody against FGF 8
37. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium
38. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor
39. Tumour angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
40. Tumour angiogenesis correlates with metastasis in invasive prostate cancer
41. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium